2013

Faculty in or associated with the UB medical school are involved in four of five research projects that have received grants from the Catalyst Fund.

Researchers have discovered a new vaccine target for tuberculosis using a UB-patented adjuvant that boosts the potency of mucosal vaccines.

A record number of participants presented their work at this year’s Medical Student Research Forum.

An exchange student investigating the metabolic exchange that occurs between myelin and axons has received an award from the Center for Undergraduate Research and Creative Activities.

Barry S. Willer, PhD, has received the 2012 Research Award from the North American Brain Injury Society.

Ji Li, PhD, assistant professor of pharmacology and toxicology, received a $198,000 grant to study a novel signaling pathway that, when activated, helps protects the heart from damage caused by ischemia.

Stephen Rudin, PhD, has won a $2.5 million grant to continue developing state-of-the-art technology within a new class of imaging detectors.

Innovations developed at least in part by faculty at UB’s School of Medicine and Biomedical Sciences accounted for nearly 40 percent of the provisional patent applications filed by the university in 2012.

UB researchers have identified specific roles for two innate immune pathways that drive acute lung injury—findings that may lead to the first treatment or preventive strategy for the condition.

Laurene M. Tumiel-Berhalter, PhD, associate professor of family medicine, has received an $800,000 grant to assess the needs of a cohort of patients with complex chronic disease.

Ali A. El Solh, MD, professor of medicine, has edited and coauthored the first textbook on managing obese patients in critical care.

Margarita L. Dubocovich, PhD, has been named a fellow of the American College of Neuropsychopharmacology.

New UB research shows how defects in an important neurological pathway in early development may be responsible for the onset of schizophrenia later in life.

Jun-Xu Li, MD, PhD, has been named councilor of the Behavioral Pharmacology Division of the American Society of Pharmacology and Experimental Therapeutics.

Andrew Talal, MD, chief of the Division of Gastroenterology, Hepatology and Nutrition, presented his research at the 63rd annual meeting of the American Association for the Study of Liver Disease.

Alex Morrison-Nozik is a finalist for the American Society of Pharmacology and Experimental Therapeutics’ Graduate Student Best Abstract Award.

Arin Bhattacharjee, PhD, assistant professor of pharmacology and toxicology, will use a $1.7 million grant to study mechanisms underlying peripheral neuropathy.

A pharmaceutical firm developing a new therapy for muscular dystrophy is open for business in UB’s New York State Center of Excellence in Bioinformatics and Life Sciences.

Avery Ellis, MD, PhD, associate professor of medicine and physiology and senior associate dean for medical curriculum, is one of eight faculty members from top U.S. institutions chosen to create scenarios for simulations used by medical students.

UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.

Jerome A. Roth, PhD, will use a $2 million grant from the National Institute for Occupational Safety and Health to study hearing loss resulting from long-term exposure to manganese and noise.

The AIDS Center/Immunodeficiency Services Clinic at Erie County Medical Center has won the 2012 New York State Department of Health AIDS Institute Award for Excellence in Quality Performance.

Pregnant women suffering from hyperemesis gravidarum—the rare and debilitating morning sickness that afflicted Kate Middleton—benefit from the anti-seizure drug gabapentin, according to a small pilot study conducted by Thomas Guttuso Jr., MD.

The Office of Communications has received the highest honor from the Association of American Medical College Group on Institutional Advancement for its transformation of the Department of Psychiatry website.

Twenty-one faculty members joined the medical school in the latter half of 2012.

UB recently acquired land at 960 Washington St., a step forward in the first phase of the $375 million plan to move the medical school to the Buffalo Niagara Medical Campus.

L. Nelson Hopkins, MD, has achieved the highest faculty rank in the SUNY system.

Six fellowship and residency programs have received Outstanding Accreditation Awards from the Office of Graduate Medical Education.

Members of the Pharmacology and Toxicology Graduate Student Association recently visited a Buffalo public school to conduct experiments with students and spark their interest in science.

Researchers at UB and the local company Immco Diagnostics have discovered novel antibodies that will allow for much earlier diagnosis of an autoimmune disease affecting more than 4 million Americans.

Animals that are socially isolated for long periods make less myelin in the region of the brain responsible for complex emotional and cognitive behavior, according to researchers at UB and Mt. Sinai School of Medicine.

With ongoing support from Research to Prevent Blindness, UB ophthalmology researchers are making discoveries that advance understanding of eye diseases.